Share information
251.30 €
-1.02 %
26/03/2026 17:37
-1.02 %
Open
High
Low
Volume
253.40 €
253.60 €
250.00 €
196,119
Latest News
26-Mar-2026
UCB receives positive CHMP opinion for new ZILBRYSQ[®]▼ (zilucoplan) pre-filled pen in EU for adults living with generalized myasthenia gravis
24-Mar-2026
UCB Selects Georgia for New U.S. Biologics Manufacturing Facility; ~$5B Economic Impact and ~330 Permanent Jobs
20-Mar-2026
Acquisition of own shares
13-Mar-2026
Share Repurchase Program 2026 to cover UCB's Long Term Incentive Plans for employees